Yuki et al., 1992 - Google Patents
Improved serodiagnosis of chronic hepatitis C in Japan by a second‐generation enzyme‐linked immunosorbent assayYuki et al., 1992
- Document ID
- 11241501486209218507
- Author
- Yuki N
- Hayashi N
- Hagiwara H
- Takehara T
- Oshita M
- Kasahara A
- Fusamoto H
- Kamada T
- Publication year
- Publication venue
- Journal of medical virology
External Links
Snippet
To clarify the role of hepatitis C virus (HCV) infection in chronic liver disease, sera from Japanese patients which were negative by the original anti‐HCV assay (Ortho) were subjected to a second‐generation anti‐HCV assay based on a combination of structural …
- 238000002965 ELISA 0 title abstract description 21
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
- C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse Transcribing DNA Viruses
- C12N2730/00011—Reverse Transcribing DNA Viruses
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hagiwara et al. | Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α | |
Féray et al. | Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation | |
Mita et al. | Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer | |
Ohkoshi et al. | Prevalence of antibody against non‐A, non‐B hepatitis virus in Japanese patients with hepatocellular carcinoma | |
Yamada et al. | Hepatitis C virus genotypes are not responsible for development of serious liver disease | |
Féray et al. | Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis | |
Chu et al. | The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B | |
Yuki et al. | Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma | |
Shih et al. | Serum hepatitis B virus DNA in healthy HBsAg‐negative Chinese adults evaluated by polymerase chain reaction | |
Sheu et al. | Prevalence of anti‐HCV and HCV viremia in hemodialysis patients in Taiwan | |
TANAKA et al. | Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: a multi‐institution analysis | |
Kao et al. | Mixed infections of hepatitis C virus as a factor in acute exacerbations of chronic type C hepatitis | |
Zignego et al. | “Inapparent” hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease | |
Yuki et al. | Improved serodiagnosis of chronic hepatitis C in Japan by a second‐generation enzyme‐linked immunosorbent assay | |
Al‐Faleh et al. | Hepatitis C virus genotypes in patients with chronic liver disease and haemodialysis patients from Saudi Arabia | |
Ohkoshi et al. | Detection of hepatitis C virus RNA in sera and liver tissues of non‐A, non‐B hepatitis patients using the polymerase chain reaction | |
Takeda et al. | Hepatitis C virus infection in hepatocellular carcinoma. Detection of plus‐strand and minus‐strand viral RNA | |
Wang et al. | Posttransfusion hepatitis revisited by hepatitis C antibody assays and polymerase chain reaction | |
Tuveri et al. | Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections | |
Yuki et al. | HCV RNA and antibody to HCV core protein in Japanese patients with chronic liver disease | |
Kakumu et al. | Long‐term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C | |
Ichimura et al. | Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease | |
Song et al. | Markers of hepatitis C and B virus infections among blood donors in Ho Chi Minh City and Hanoi, Vietnam. | |
Yuki et al. | Serodiagnosis of chronic hepatitis C in Japan by second-generation recombinant immunoblot assay | |
Yuki et al. | Clinical characteristics and antibody profiles of chronic hepatitis C patients: relation to hepatitis C virus genotypes |